monolithic: "My realistic opined expectations are around $2.80 to $5.40 per share based upon Denselight moving forward while POET develops further."
I'll add: I'm a fan of the DenseLight purchase. I think it adds value and will speed our transition. But I'd be surprised (happily so!) to see DL put up the kind of numbers in the near term needed to, on it's own, get us worth a billion dollars (in the $3+ range). Maybe you see something I don't?
Now, if you factor in the gains we've made in the last two years, and add that to the Pellegrino evaluation (however accurate you think that is), then could be? But unless DenseLight unveils an ace up its sleeve (diabetes tester ready to go?), they likely won't solely give us the hockey-stick rise we're waiting for, IMO.
